One of the most frequent translocations, t(8; 21), representing 12–15% of patients with AML, results in fusion of the DNA-binding domain of RUNX1 (also known as AML1) to the eight-twenty-one (ETO, also known as MTG8) co-repressor. This evidence concerns the gene RUNX1 and acute myeloid leukemia.